A. Khachatryan

606 total citations
22 papers, 458 citations indexed

About

A. Khachatryan is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, A. Khachatryan has authored 22 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 4 papers in Epidemiology and 4 papers in Emergency Medicine. Recurrent topics in A. Khachatryan's work include HIV/AIDS Research and Interventions (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV Research and Treatment (3 papers). A. Khachatryan is often cited by papers focused on HIV/AIDS Research and Interventions (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV Research and Treatment (3 papers). A. Khachatryan collaborates with scholars based in United States, Switzerland and Germany. A. Khachatryan's co-authors include Jennifer Stephens, Seema Haider, Sajjad Haider, Michal Kantecki, Ľuboš Drgoňa, Claudie Charbonneau, Rosemary A. Barnes, Dipen Patel, Keith S. Kaye and Kit N. Simpson and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and European Heart Journal.

In The Last Decade

A. Khachatryan

20 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Khachatryan United States 9 296 122 87 72 62 22 458
Giuseppe Pontrelli Italy 16 99 0.3× 184 1.5× 95 1.1× 119 1.7× 52 0.8× 34 807
Valerie A. Chirurgi United States 12 175 0.6× 89 0.7× 72 0.8× 96 1.3× 17 0.3× 16 360
José G. Castro United States 13 260 0.9× 256 2.1× 67 0.8× 24 0.3× 15 0.2× 45 632
Ann Macintyre United States 11 217 0.7× 236 1.9× 136 1.6× 170 2.4× 12 0.2× 22 902
Matteo Vassallo France 11 151 0.5× 85 0.7× 28 0.3× 13 0.2× 135 2.2× 33 382
Sally Houston United States 11 630 2.1× 578 4.7× 25 0.3× 23 0.3× 18 0.3× 19 885
Sara H Bares United States 15 475 1.6× 228 1.9× 42 0.5× 26 0.4× 232 3.7× 58 773
R Michael Whitby Australia 8 115 0.4× 184 1.5× 53 0.6× 16 0.2× 14 0.2× 17 564
Dioclécio Campos Brazil 10 145 0.5× 98 0.8× 162 1.9× 19 0.3× 14 0.2× 15 408
G. L. Monekosso Cameroon 12 114 0.4× 39 0.3× 73 0.8× 13 0.2× 92 1.5× 37 466

Countries citing papers authored by A. Khachatryan

Since Specialization
Citations

This map shows the geographic impact of A. Khachatryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Khachatryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Khachatryan more than expected).

Fields of papers citing papers by A. Khachatryan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Khachatryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Khachatryan. The network helps show where A. Khachatryan may publish in the future.

Co-authorship network of co-authors of A. Khachatryan

This figure shows the co-authorship network connecting the top 25 collaborators of A. Khachatryan. A scholar is included among the top collaborators of A. Khachatryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Khachatryan. A. Khachatryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Thomas E., et al.. (2025). Unmet Medication Coverage Needs among Adults with Attention Deficit/Hyperactivity Disorder (ADHD). Psychopharmacology Bulletin. 47(4). 18–28.
2.
Brown, Thomas E., et al.. (2025). Persisting Psychosocial Impairments in Adults Being Treated with Medication for Attention Deficit/Hyperactivity Disorder. Psychopharmacology Bulletin. 47(4). 8–17. 1 indexed citations
3.
Khachatryan, A., et al.. (2021). Regenerative therapy for the treatment of periimplantitis. 107(3). 50–57. 5 indexed citations
4.
Khachatryan, A., et al.. (2020). PND94 Quality of Life of Dravet Syndrome Patients: A CROSS-Sectional Study in France. Value in Health. 23. S639–S639. 1 indexed citations
5.
6.
7.
Adler, Lenard A., et al.. (2018). Establishing US norms for the Adult ADHD Self-Report Scale (ASRS-v1.1) and characterising symptom burden among adults with self-reported ADHD. International Journal of Clinical Practice. 73(1). e13260–e13260. 33 indexed citations
8.
Kaye, Keith S., Dipen Patel, Jennifer Stephens, et al.. (2015). Rising United States Hospital Admissions for Acute Bacterial Skin and Skin Structure Infections: Recent Trends and Economic Impact. PLoS ONE. 10(11). e0143276–e0143276. 79 indexed citations
9.
10.
Flack, Andrea, Wolfgang Fiedler, Julio Blas, et al.. (2015). Data from: Costs of migratory decisions: a comparison across eight white stork populations. Movebank. 6 indexed citations
11.
Khachatryan, A., et al.. (2014). GRAM+ Acute Bacterial Skin And Skin Structure Infections (ABSSSI): Recent Trends In United States Hospital Admissions. Value in Health. 17(3). A266–A266. 3 indexed citations
12.
Solem, Caitlyn T., Sonya J. Snedecor, A. Khachatryan, et al.. (2014). Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population. PLoS ONE. 9(5). e98152–e98152. 23 indexed citations
13.
14.
Simpson, Kit N., Kristin A. Hanson, Gale Harding, et al.. (2013). Patient reported outcome instruments used in clinical trials of HIV-infected adults on NNRTI-based therapy: a 10-year review. Health and Quality of Life Outcomes. 11(1). 164–164. 38 indexed citations
15.
Snedecor, Sonya J., A. Khachatryan, Richard Chambers, et al.. (2013). The Prevalence of Transmitted Resistance to First-Generation Non-Nucleoside Reverse Transcriptase Inhibitors and Its Potential Economic Impact in HIV-Infected Patients. PLoS ONE. 8(8). e72784–e72784. 19 indexed citations
16.
Wu, Albert W., Kristin A. Hanson, Gale Harding, et al.. (2013). Responsiveness of the MOS-HIV and EQ-5D in HIV-infected adults receiving antiretroviral therapies. Health and Quality of Life Outcomes. 11(1). 42–42. 39 indexed citations
17.
Drgoňa, Ľuboš, A. Khachatryan, Jennifer Stephens, et al.. (2013). Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species. European Journal of Clinical Microbiology & Infectious Diseases. 33(1). 7–21. 103 indexed citations
18.
Simpson, Kit N., Albert W. Wu, Luke Boulanger, et al.. (2012). PIN11 Costs of Adverse Events Among Patients With Human Immunodeficiency Virus Treated With Non-Nucleoside Reverse Transcriptase Inhibitors. Value in Health. 15(4). A238–A239. 1 indexed citations
19.
Snedecor, Sonya J., et al.. (2012). The prevalence and economic burden of 1st‐generation NNRTI resistance. Journal of the International AIDS Society. 15(S4). 1–1. 1 indexed citations
20.
Khachatryan, A., Sylvie Guerder, F Palluault, et al.. (1997). Targeted expression of the neuropeptide calcitonin gene-related peptide to β cells prevents diabetes in NOD mice. The Journal of Immunology. 158(3). 1409–1416. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppe Pontrelli Breakdown of academic impact, for papers by Valerie A. Chirurgi Breakdown of academic impact, for papers by José G. Castro Breakdown of academic impact, for papers by Ann Macintyre Breakdown of academic impact, for papers by Matteo Vassallo Breakdown of academic impact, for papers by Sally Houston Breakdown of academic impact, for papers by Sara H Bares Breakdown of academic impact, for papers by R Michael Whitby Breakdown of academic impact, for papers by Dioclécio Campos Breakdown of academic impact, for papers by G. L. Monekosso
Rankless by CCL
2026